Press Release

Global Pharmaceutical Excipients Market Expected to Grow at a CAGR of 4.1% between 2024 and 2032

Pharmaceutical Excipients Market

According to a new report by EMR titled, 'Global Pharmaceutical Excipients Market Report and Forecast 2024-2032', the global pharmaceutical excipients market reached a value of USD 8.64 billion in 2023. The market is further expected to grow at a CAGR of 4.1% in the forecast period of 2024-2032 to reach a value of USD 12.40 billion by 2032.

Europe is the leading market in the global pharmaceutical excipients market, driven by the large presence of pharmaceutical key players having, who have extensive production capacities, thus, high consumption rates of excipients. The rising demand for superior pharmaceutical products, biosimilars, and generics have led to accelerated growth in the pharmaceutical excipients industry over the forecast period.

 

Ashland Global Holdings Inc. (NYSE: ASH) and BASF SE (ETR: BAS) are some of the leading companies in the global pharmaceutical excipients market. In August 2017, BASF SE inaugurated the opening of its pharma technical lab at its Innovation Campus Asia Pacific, which is situated in Navi Mumbai, India. The facility is called “BASF Pharma Solutions Lab” and caters to the rapidly growing pharmaceutical market in South Asia, particularly generic drug manufacturing, which holds the largest share of the sector in India. Such developments by the key players are expected to push the growth of the global pharmaceutical excipients market in the coming years.

 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis by Product, Functionality, Formulation, and Region:

  • The pharmaceutical excipients market, on the basis of product, is divided into organic chemicals and inorganic chemicals, among others. Organic chemicals are further divided into oleochemicals, carbohydrates, petrochemicals, and proteins, among others, while inorganic chemicals are further divided into calcium phosphate, metal oxides, halites, calcium carbonate, and calcium sulphate, among others. Within organic chemicals, carbohydrates are sub-divided into sugars, cellulose, and starch.
  • On the basis of functionality, the pharmaceutical excipients market is segmented into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colourants, lubricants and glidants, preservatives, and emulsifying agents, among others.
  • The market is categorised on the basis of the formulation into oral formulations, topical formulations, and parenteral formulations, among others. The oral formulations are further divided into tablets, capsules, and liquid formulations, with capsules sub-divided into hard gelatin capsules and soft gelatin capsules.
  • Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

 

Key Findings of the Report:

  • The global pharmaceutical excipients market is driven by the rapidly increasing pharmaceutical industry, along with the advances in functional excipients.
  • The rising use of orphan drugs and the growing use of biopharmaceuticals are further aiding the market growth.
  • With the introduction of multifunctional excipients, the focus of pharmaceutical manufacturing is shifting towards the emerging markets, further enhancing the market growth.
  • Also, the rising biosimilar sector is providing significant growth opportunities in the market for pharmaceutical excipients.

 

Key Offerings of the Report:

  • The EMR report gives an overview of the global pharmaceutical excipients market for the periods (2018-2023) and (2024-2032).
  • The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the product, functionality, formulation, and regional markets of the global pharmaceutical excipients. 
  • It gives an in-depth look at the regional price trends in the global pharmaceutical excipients market.
  • The report assesses the market based on the SWOT and Porter’s Five Forces models.

 

Dupont De Nemours, Inc., Roquette Frères, Ashland Global Holdings Inc., Evonik Industries AG, BASF SE, Kerry Group PLC, Croda International Plc, ABF Ingredients Limited, Archer Daniels Midland Company, The Lubrizol Corporation, Innophos Holdings Inc., WACKER Chemie AG among others, are the key players in the global pharmaceutical excipients market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

 

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

 

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

 

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER